Mercedes Tuin

Director Life Sciences & MedTech at Brabantse Ontwikkelings Maatschappij (BOM)

Bussum, North Holland

Overview

Mercedes Tuin is a Venture Capital professional specializing in Life Sciences and MedTech, currently serving as an Investment Director at Brabantse Ontwikkelings Maatschappij (BOM). With a strong background in Medical Technology and extensive experience in deal execution, she has successfully led investments in companies like RiboPro and holds board positions in various organizations within the industry.

Work Experience

Brabantse Ontwikkelings Maatschappij (BOM)

Investment Director Life Sciences & MedTech
2023 - Current
With a team of 6 people we invest in start-ups and scale-ups developing innovative therapeutics, diagnostics, medical devices and healthcare solutions.
Sr Investment Manager Life Sciences-MedTech & Strategy Theme lead Healthy Future
2019 - 2023
BOM Brabant Ventures is a Venture Capital investor realising impact in Noord Brabant enabling start-ups and scale-ups to grow. De BOM investeert in schaalbare start- en scale ups met groeipotentie en een sterke link met Noord-Brabant. BOM Brabant Ventures portfolio includes Acerta Pharma, Atro Medical, BioConnection, BioNovion (Aduro), Cytomate, Cytura, DegenRx, Glycostem, RiboPro, , IME Technologies, Innatoss, InProcessLSP, Lead Pharma, Cristal Therapeutics, Medeye, NTRC, Preceyes, Salvia, SamanTree Medicsl, Synaffix, Ventinova and DegenRx.
Investment Manager Life Sciences & Medtech
2018 - 2019